FDA UDI Not in Commercial Distribution 🇺🇸 United States

Anti-AtherOxTM IgG Test Kit (OxLDL-B2GPI IgG Antibody)

DI: 00855360006236 · Model: 11854 · CORGENIX MEDICAL CORPORATION
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1

Basic Information

Brand Name
Anti-AtherOxTM IgG Test Kit (OxLDL-B2GPI IgG Antibody)
Primary DI
00855360006236
Version / Model
11854
Catalog Number
11854
Company Name
CORGENIX MEDICAL CORPORATION
Labeler DUNS
619834542
Distribution Status
Not in Commercial Distribution
Device Count in Pkg
1
Record Status
Published
Publish Date
2016-08-08
Public Version
3
Public Version Date
2018-07-06
Public Version Status
Update
Public Device Record Key
2611afe2-115f-40d5-8020-415fffb22dc8
Distribution End Date
2017-02-21

Device Description

INTENDED USE An enzyme-linked immunoassay (ELISA) for the detection of IgG antibodies to complexes formed by oxidized low-density lipoprotein (oxLDL) with β2-glycoprotein I (β2GPI) in individuals with systemic lupus erythematosus (SLE) and lupus-like disorders (antiphospholipid syndrome). For In Vitro Diagnostic Use Only. SUMMARY AND EXPLANATION OF THE ASSAY The antiphospholipid syndrome (APS) is one of the most common causes of acquired hypercoagulability (thrombophilia) It is frequently diagnosed in the context of a systemic autoimmune disorder such as SLE (secondary APS), however, it may also occur in the absence of an obvious underlying disease (primary APS). Oxidative stress and oxLDL formation are common in patients with SLE and APS suggesting an important relationship between lipid peroxidation and clotting activation (hypercoagulability). The presence of circulating IgG anti-oxLDL-β2GPI antibodies seem to be etiologically important. PRINCIPLE OF THE TEST This test is an indirect ELISA detecting IgG anti-oxLDL-β2GPI antibodies. Diluted serum samples, calibrator(s), and controls are incubated in microwells coated with the oxLDL- β2GPI complex. After the removal of unbound serum proteins by washing, anti-human IgG antibodies, labeled with horseradish peroxidase (HRP), are added. Following another wash, the bound enzyme-antibody conjugate is assayed by the addition of tetramethylbenzidine (TMB) and hydrogen peroxide (H2O2) as the chromogenic substrate. Color develops in the wells at an intensity proportional to the serum concentration of IgG anti-oxLDL-β2GPI antibody. Results are obtained by reading the OD of each well in a spectrophotometer. Calibrator sera are provided, with the IgG anti-oxLDL-β2GPI antibody concentration expressed in G Units. A log-log regression analysis is performed with calibrator values plotted against calibrator mean O.D.’s. Controls and patient results are determined from the calibration curve. Refer to product package insert.

Device Characteristics

Single Use
Yes
Prescription Use (Rx)
Yes
Over the Counter (OTC)
No
Kit
Yes
Combination Product
No
HCT/P
No
Contains NRL
No
Not Made with NRL
No
MRI Safety
Labeling does not contain MRI Safety Information
Direct Marking Exempt
No
PM Exempt
No
Has Serial Number
No
Has Lot/Batch Number
Yes
Has Manufacturing Date
No
Has Expiration Date
Yes
Has Donation ID
No

Sterilization

Is Sterile
No
Sterilization Prior Use
No

Product Codes

Code Name
MSV System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)

GMDN Terms

Code Name
62226 Oxidized low density lipoprotein-B2-glycoprotein I (OxLDL-B2GPI) complex antibody IVD, kit, enzyme immunoassay (EIA)

Identifiers

Type ID
Primary 00855360006236

Customer Contacts

Premarket Submissions

Submission Number Supplement Number
K072032 000

Storage Conditions

Type
Storage Environment Temperature
Temperature Range
2 – 8 Degrees Celsius